Recursion Pharmaceuticals IPO
This company has completed its IPO and is now publicly traded (RXRX).
Industry
Biotechnology
Market Cap
$2.5B
Total Funding
$939M
Headquarters
Salt Lake City, UT
View full Recursion Pharmaceuticals profile →